Why the study?
Does higher HDL-C reduce all-cause and cardiovascular mortality in patients with kidney dysfunction undergoing coronary angiography?
Does higher HDL-C reduce all-cause and cardiovascular mortality in patients with kidney dysfunction undergoing coronary angiography?
Higher HDL-C levels are not associated with reduced mortality risk in patients with reduced kidney function, suggesting abnormal HDL function in this population.
No takes yet. Share an insight, caveat, or question.
Higher HDL-C may not inform mortality risk in reduced eGFR; leaves open whether HDL dysfunction modifies outcomes in CKD.
Zewinger et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: